Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
基本信息
- 批准号:10401470
- 负责人:
- 金额:$ 25.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-17 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgonistAnimalsAssisted Reproductive TechnologyCalciumCationsCell membraneCell physiologyCellsClinicCompetenceContraceptive methodsCountryCouplesDataDetectionDevelopmentDiagnosisDivalent CationsElectrophysiology (science)EmbryoEmbryonic DevelopmentEndoplasmic ReticulumEventFamilyFertilityFertilizationGenesGenetic ModelsGenetic TranscriptionGerm CellsGoalsHealthHomeostasisHumanImageIn VitroInfertilityIon ChannelKnockout MiceKnowledgeLaboratoriesMammalsMediatingMethodsMissionModelingMolecularMusOocytesOutcomePathway interactionsPeriodicityPermeabilityPharmacologyPhosphotransferasesPhysiologicalPhysiologyPre-implantation Embryo DevelopmentProtocols documentationPublic HealthReagentRecoveryRegulationReportingReproductionResearchRoleSignal TransductionSystemTRP channelTestingTherapeuticTranscriptTranslatingUnited States National Institutes of HealthWomanantagonistbaseburden of illnessconditional knockouteggfemale fertilitygain of functionhuman diseaseimaging geneticsimprovedinfertility treatmentinhibitorinnovationinsightmembernovelnovel strategiesoocyte maturationoocyte qualitypregnantpreventreceptorreproductivereproductive successresponsezygote
项目摘要
There is a persistent gap in our knowledge of the molecules and mechanisms that mediate Ca2+ influx
into oocytes and eggs. Ca2+ influx is required for egg activation and embryo development in all mammals,
including human beings. This gap in our knowledge therefore represents a serious impediment, as until
it is filled we cannot physiologically modulate Ca2+ influx or objectively diagnose and treat infertility
associated with disturbances in Ca2+ homeostasis. The long-term goal is to understand how Ca2+
homeostasis is regulated in oocytes and eggs and identify its molecular effectors. The objective here is
to identify the Ca2+ channel(s) that mediate Ca2+ influx during maturation and fertilization and characterize
their regulatory mechanisms. Mouse oocytes/eggs are a great model because they display distinctive
Ca2+ entry during maturation and fertilization, and Ca2+ release is required for egg activation. The central
hypothesis is that expression and/or distinct regulation of underdetermined Ca2+ channels on the plasma
membrane underlies Ca2+ influx in oocytes, its inactivation during maturation and its recovery after
fertilization. This hypothesis was conceived based on extensive preliminary data. The rationale for this
research is that once the channels are identified, a better understanding of the molecular determinants
of oocyte maturation and fertilization will be gained. The findings here also have the potential to translate
into therapeutic methods to assist infertile couples in this country. We plan to test our central hypothesis
by pursuing the following specific aims: 1) Identify the Ca2+ channel(s) that mediate Ca2+ influx in oocytes
prior to and during maturation; and 2) Identify the Ca2+ influx channel(s) that support oscillations after
fertilization. Under Aim 1, Ca2+ imaging, pharmacology, conditional knockout mice, and electrophysiology
will be used to identify the active channel(s) and to assess the impact of Ca2+ influx on maturation; the
role of a TRPM7-like current recently discovered by the applicant and collaborators will be closely
examined. Under Aim 2, the signaling mechanism(s) whereby fertilization stimulates Ca2+ influx and the
contributing channel(s) will be determined. A novel approach that overcomes the inactivation of Ca2+
influx in eggs will facilitate these studies. Genetic models and electrophysiology will confirm the function
of these channel(s) during fertilization. The research in this application is innovative because it combines
electrophysiology, pharmacology and new KO lines, approach that has served to identify two new
channels in oocytes, including TRPM7, whose global deletion is embryonic lethal at E7.5. The
contribution of the proposed project is significant because it is expected to allow physiological modulation
of Ca2+ entry in oocytes and eggs that will produce new conditions and activation protocols for use in the
clinic. It will also expand our understanding of the impact of Ca2+ homeostasis on oocyte competence
and infertility.
我们对介导Ca2+涌入的分子和机制的知识存在持续的差距
进入卵母细胞和鸡蛋。在所有哺乳动物中,卵子激活和胚胎发育都需要Ca2+流入,
包括人类。因此
它填充了我们不能在生理上调节Ca2+涌入或客观地诊断和治疗不育症
与CA2+稳态中的障碍有关。长期目标是了解CA2+如何
稳态受到卵母细胞和卵的调节,并鉴定其分子效应子。这里的目的是
确定在成熟和受精过程中介导Ca2+流入的Ca2+通道
他们的监管机制。小鼠卵母细胞/鸡蛋是一个很好的模型,因为它们显示出独特的模型
Ca2+在成熟和受精过程中进入,鸡蛋激活需要Ca2+释放。中央
假设是等离子体上不确定的Ca2+通道的表达和/或不同的调节
膜是卵母细胞中Ca2+涌入的基础,其成熟过程中的失活以及其恢复
受精。该假设是基于广泛的初步数据来构想的。理由
研究是,一旦确定了通道,就可以更好地理解分子决定因素
将获得卵母细胞成熟和受精的。这里的发现也有可能翻译
进入治疗方法,以协助这个国家的不育夫妇。我们计划检验我们的中心假设
通过追求以下特定目的:1)确定介导卵母细胞Ca2+涌入的Ca2+通道
成熟之前和期间; 2)确定支持振荡之后振荡的CA2+涌入通道
受精。在AIM 1,CA2+成像,药理学,有条件敲除小鼠和电生理学下
将用于识别活性通道并评估Ca2+涌入对成熟的影响;这
申请人和合作者最近发现的类似于TRPM7的电流的作用将紧密
检查。在AIM 2下,施肥刺激Ca2+流入的信号传导机制
将确定贡献渠道。一种克服CA2+失活的新方法
卵中的涌入将有助于这些研究。遗传模型和电生理学将确认该功能
在受精过程中这些通道。该应用程序中的研究具有创新性,因为它结合了
电生理学,药理学和新的KO系,方法已经确定了两个新的
卵母细胞中的通道,包括TRPM7,其全局缺失在E7.5处是胚胎致死的。这
拟议项目的贡献很大,因为它有望允许生理调节
在卵母细胞和卵中的Ca2+进入,这些卵母细胞和卵将产生新的条件和激活方案
诊所。它还将扩展我们对CA2+稳态对卵母细胞能力的影响的理解
和不育。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SPERM FACTORS AND EGG ACTIVATION: ICSI and the discovery of the sperm factor and PLCZ1.
- DOI:10.1530/rep-21-0487
- 发表时间:2022-05-23
- 期刊:
- 影响因子:3.8
- 作者:Gupta, Neha;Akizawa, Hiroki;Lee, Hoi Chang;Fissore, Rafael A.
- 通讯作者:Fissore, Rafael A.
Multidrug resistance transporter-1 dysfunction perturbs meiosis and Ca2+ homeostasis in oocytes.
- DOI:10.1530/rep-22-0192
- 发表时间:2023-01-01
- 期刊:
- 影响因子:3.8
- 作者:Nabi, Dalileh;Bosi, Davide;Gupta, Neha;Thaker, Nidhi;Fissore, Rafael;Brayboy, Lynae M.
- 通讯作者:Brayboy, Lynae M.
Editorial: The Fertilization Success From the Oocyte's Perspective.
- DOI:10.3389/fcell.2021.810420
- 发表时间:2021
- 期刊:
- 影响因子:5.5
- 作者:Michaut MA;Souza-Fabjan JMG;Fissore RA
- 通讯作者:Fissore RA
The eggstraordinary story of how life begins.
- DOI:10.1002/mrd.23083
- 发表时间:2019-01
- 期刊:
- 影响因子:2.5
- 作者:Parrington J;Arnoult C;Fissore RA
- 通讯作者:Fissore RA
Deletion of TRPV3 and CaV3.2 T-type channels in mice undermines fertility and Ca2+ homeostasis in oocytes and eggs.
小鼠 TRPV3 和 CaV3.2 T 型通道的缺失会破坏卵母细胞和卵子的生育能力和 Ca2 稳态。
- DOI:10.1242/jcs.257956
- 发表时间:2021
- 期刊:
- 影响因子:4
- 作者:Mehregan,Aujan;Ardestani,Goli;Akizawa,Hiroki;Carvacho,Ingrid;Fissore,Rafael
- 通讯作者:Fissore,Rafael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rafael Antonio Fissore其他文献
Rafael Antonio Fissore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rafael Antonio Fissore', 18)}}的其他基金
Mammalian Fertilization: Identifying the second sperm factor that induces residual calcium oscillations and its contributions to egg activation
哺乳动物受精:识别诱导残留钙振荡的第二个精子因子及其对卵子激活的贡献
- 批准号:
10574938 - 财政年份:2022
- 资助金额:
$ 25.33万 - 项目类别:
Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
- 批准号:
9766344 - 财政年份:2018
- 资助金额:
$ 25.33万 - 项目类别:
Frontiers in Reproduction (FIR) Training Course
生殖前沿 (FIR) 培训课程
- 批准号:
10617172 - 财政年份:2014
- 资助金额:
$ 25.33万 - 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
- 批准号:
6687127 - 财政年份:2003
- 资助金额:
$ 25.33万 - 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
- 批准号:
6772484 - 财政年份:2003
- 资助金额:
$ 25.33万 - 项目类别:
相似国自然基金
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载自组装型非核苷类STING激动剂的亚精胺水凝胶用于抗肿瘤免疫治疗及机制研究
- 批准号:82303561
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向SIRT3小分子激动剂调控三阴性乳腺癌细胞自噬和免疫微环境的机制研究
- 批准号:82373193
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis
肠胶质细胞作为缓解子宫内膜异位症症状的可能目标
- 批准号:
10625609 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
A Nonhuman Primate Model for Postoperative Delirium and Working Memory Impairment
术后谵妄和工作记忆损伤的非人类灵长类动物模型
- 批准号:
10592515 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别: